Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...

While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

Researchers at the University of Minnesota have developed YCT-529, a non-hormonal male birth control pill showing efficacy in ...

Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...

While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

MINNEAPOLIS — The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their greatest lesson from 2024 ...

Through this partnership, Pentec will act as a distribution and service provider for Luminopia, offering comprehensive support services to patients and providers. This includes navigating insurance to ...